Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study

Theunissen EL, Hutten N, Mason NL, Toennes SW, Kuypers KPC, de Sousa Fernandes Perna EB and Ramaekers JG

(2018) Br J Pharmacol, 175: 18-28.

Link to abstract

Synthetic cannabinoids (often sold as Spice or K2) have become a very popular alternative to cannabis due to their easy access and portrayed safety. Controlled studies on the behavioural effects of synthetic cannabinoids are currently lacking, which hampers risk assessments of these compounds.